SITAGLIPTIN (SITAGLIPTIN MALATE) — all Canadian products
18 DINs
12 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SITAGLIPTIN (SITAGLIPTIN MALATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02508656 | APO-SITAGLIPTIN MALATE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 25 MG | Marketed | |
| 02508664 | APO-SITAGLIPTIN MALATE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG | Marketed | |
| 02508672 | APO-SITAGLIPTIN MALATE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 100 MG | Marketed | |
| 02509415 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02509423 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02509431 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02522705 | TEVA-SITAGLIPTIN MALATE | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 25 MG | Marketed | |
| 02522713 | TEVA-SITAGLIPTIN MALATE | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG | Marketed | |
| 02522721 | TEVA-SITAGLIPTIN MALATE | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 100 MG | Marketed | |
| 02520494 | TEVA-SITAGLIPTIN MALATE / METFORMIN | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02520508 | TEVA-SITAGLIPTIN MALATE / METFORMIN | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02520516 | TEVA-SITAGLIPTIN MALATE / METFORMIN | TEVA CANADA LIMITED | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02534290 | PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 25 MG | Cancelled Post Market | |
| 02534304 | PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG | Cancelled Post Market | |
| 02534312 | PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 100 MG | Cancelled Post Market | |
| 02534223 | PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market | |
| 02534231 | PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market | |
| 02534258 | PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Tablet | Oral | SITAGLIPTIN (SITAGLIPTIN MALATE) 50 MG; METFORMIN HYDROCHLORIDE 1000 MG | Cancelled Post Market |
Browse other molecules: